148 related articles for article (PubMed ID: 17332935)
1. A new comprehensive gene expression panel to study tumor micrometastasis in patients with high-risk breast cancer.
Ferrucci PF; Rabascio C; Gigli F; Corsini C; Giordano G; Bertolini F; Martinelli G
Int J Oncol; 2007 Apr; 30(4):955-62. PubMed ID: 17332935
[TBL] [Abstract][Full Text] [Related]
2. Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer.
Corradini P; Voena C; Astolfi M; Delloro S; Pilotti S; Arrigoni G; Bregni M; Pileri A; Gianni AM
Ann Oncol; 2001 Dec; 12(12):1693-8. PubMed ID: 11843246
[TBL] [Abstract][Full Text] [Related]
3. Mammaglobin expression in leukapheresis products is a predictive marker of poor prognosis in women with high-risk breast cancer.
Ferrucci PF; Rabascio C; Mazzetta C; Cocorocchio E; Agazzi A; Vanazzi A; Cinieri S; Peccatori FA; Paolucci M; Bertolini F; Martinelli G
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6039-46. PubMed ID: 15447988
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of disseminated tumor cells as detected by quantitative real-time reverse-transcriptase polymerase chain reaction in patients with breast cancer.
Benoy IH; Elst H; Philips M; Wuyts H; Van Dam P; Scharpé S; Van Marck E; Vermeulen PB; Dirix LY
Clin Breast Cancer; 2006 Jun; 7(2):146-52. PubMed ID: 16800974
[TBL] [Abstract][Full Text] [Related]
5. Disseminated tumor cells in bone marrow assessed by TWIST1, cytokeratin 19, and mammaglobin A mRNA predict clinical outcome in operable breast cancer patients.
Tjensvoll K; Oltedal S; Farmen RK; Shammas FV; Heikkilä R; Kvaløy JT; Gilje B; Smaaland R; Nordgård O
Clin Breast Cancer; 2010 Oct; 10(5):378-84. PubMed ID: 20920982
[TBL] [Abstract][Full Text] [Related]
6. Real-time RT-PCR correlates with immunocytochemistry for the detection of disseminated epithelial cells in bone marrow aspirates of patients with breast cancer.
Benoy IH; Elst H; Van der Auwera I; Van Laere S; van Dam P; Van Marck E; Scharpé S; Vermeulen PB; Dirix LY
Br J Cancer; 2004 Nov; 91(10):1813-20. PubMed ID: 15505629
[TBL] [Abstract][Full Text] [Related]
7. A small subgroup of operable breast cancer patients with poor prognosis identified by quantitative real-time RT-PCR detection of mammaglobin A and trefoil factor 1 mRNA expression in bone marrow.
Tjensvoll K; Gilje B; Oltedal S; Shammas VF; Kvaløy JT; Heikkilä R; Nordgård O
Breast Cancer Res Treat; 2009 Jul; 116(2):329-38. PubMed ID: 18846421
[TBL] [Abstract][Full Text] [Related]
8. Real-time RT-PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer.
Benoy IH; Elst H; Philips M; Wuyts H; Van Dam P; Scharpé S; Van Marck E; Vermeulen PB; Dirix LY
Br J Cancer; 2006 Mar; 94(5):672-80. PubMed ID: 16495933
[TBL] [Abstract][Full Text] [Related]
9. Detection of breast cancer cell contamination in leukapheresis product by real-time quantitative polymerase chain reaction.
Leone F; Perissinotto E; Viale A; Cavalloni G; Taraglio S; Capaldi A; Piacibello W; Torchio B; Aglietta M
Bone Marrow Transplant; 2001 Mar; 27(5):517-23. PubMed ID: 11313686
[TBL] [Abstract][Full Text] [Related]
10. Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes: possible relevance to the assays for the detection of micrometastatic breast cancer.
Ballestrero A; Garuti A; Bertolotto M; Rocco I; Boy D; Nencioni A; Ottonello L; Patrone F
Br J Cancer; 2005 May; 92(10):1948-52. PubMed ID: 15841077
[TBL] [Abstract][Full Text] [Related]
11. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
[TBL] [Abstract][Full Text] [Related]
12. Mammaglobin gene expression: a superior marker of breast cancer cells in peripheral blood in comparison to epidermal-growth-factor receptor and cytokeratin-19.
Grünewald K; Haun M; Urbanek M; Fiegl M; Müller-Holzner E; Gunsilius E; Dünser M; Marth C; Gastl G
Lab Invest; 2000 Jul; 80(7):1071-7. PubMed ID: 10908152
[TBL] [Abstract][Full Text] [Related]
13. Human mammaglobin RT-PCR assay for detection of occult breast cancer cells in hematopoietic products.
Silva AL; Tomé MJ; Correia AE; Passos-Coelho JL
Ann Oncol; 2002 Mar; 13(3):422-9. PubMed ID: 11996474
[TBL] [Abstract][Full Text] [Related]
14. Detection of micrometastatic cells in breast cancer by RT-pCR for the mammaglobin gene.
Bossolasco P; Ricci C; Farina G; Soligo D; Pedretti D; Scanni A; Deliliers GL
Cancer Detect Prev; 2002; 26(1):60-3. PubMed ID: 12088204
[TBL] [Abstract][Full Text] [Related]
15. Mammaglobin as a novel breast cancer biomarker: multigene reverse transcription-PCR assay and sandwich ELISA.
Zehentner BK; Persing DH; Deme A; Toure P; Hawes SE; Brooks L; Feng Q; Hayes DC; Critichlow CW; Houghton RL; Kiviat NB
Clin Chem; 2004 Nov; 50(11):2069-76. PubMed ID: 15375015
[TBL] [Abstract][Full Text] [Related]
16. Mammaglobin and maspin transcripts in blood may reflect disease progression and the effect of therapy in breast cancer.
Bitisik O; Saip P; Saglam S; Derin D; Dalay N
Genet Mol Res; 2010; 9(1):97-106. PubMed ID: 20092039
[TBL] [Abstract][Full Text] [Related]
17. Use of reverse-transcriptase polymerase chain reaction (RT-PCR) for carcinoembryonic antigen, cytokeratin 19, and maspin in the detection of tumor cells in leukapheresis products from patients with breast cancer: comparison with immunocytochemistry.
López-Guerrero JA; Gilabert PB; González EB; Sanz Alonso MA; Pérez JP; Talens AS; Oraval EA; de la Rubia Comos J; Boix SB
J Hematother; 1999 Feb; 8(1):53-61. PubMed ID: 10192302
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow micrometastases detected by RT-PCR for mammaglobin can be an alternative prognostic factor of breast cancer.
Ooka M; Tamaki Y; Sakita I; Fujiwara Y; Yamamoto H; Miyake Y; Sekimoto M; Ohue M; Sugita Y; Miyoshi Y; Ikeda N; Noguchi S; Monden M
Breast Cancer Res Treat; 2001 May; 67(2):169-75. PubMed ID: 11519865
[TBL] [Abstract][Full Text] [Related]
19. Positive bone marrow biopsy is associated with a decreased disease-free survival in patients with operable breast cancer.
Fortunato L; Mascaro A; Baldi A; Farina M; Cortese G; Ventrone MA; Amini M; Vitelli C
Ann Surg Oncol; 2009 Nov; 16(11):3010-9. PubMed ID: 19641970
[TBL] [Abstract][Full Text] [Related]
20. Detection of mammaglobin mRNA in peripheral blood is associated with high grade breast cancer: interim results of a prospective cohort study.
Mikhitarian K; Martin RH; Ruppel MB; Gillanders WE; Hoda R; Schutte del H; Callahan K; Mitas M; Cole DJ
BMC Cancer; 2008 Feb; 8():55. PubMed ID: 18289390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
